Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future
In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.
It’s a warm May day when 700 Alfa Laval employees are welcomed to Flemingsberg with signs, balloons, and friendly faces guiding them to their new office. This will be their new workplace, located at the heart of one of Sweden’s largest urban development projects, with the ambitious goal of reaching 50,000 workers, 50,000 residents, and 50,000 visitors in Flemingsberg by 2050.
“We are very pleased to have established our new premises in Flemingsberg. This expansion represents a significant improvement for our employees, our operations, and our customers. Flemingsberg is now Alfa Laval’s hub for all development of separators within the marine, energy, food, and pharma sectors. We are also establishing our Innovation Centre for pharma here, further reinforcing our commitment to innovation and growth.”
– Peter Nielsen, Alfa Laval’s Site Manager for Flemingsberg and President of the Business Unit High Speed Separators
“We are very happy to welcome Alfa Laval to Flemingsberg and as a tenant of Fabege. Their presence strengthens the area’s position as a dynamic and innovative hub for research and development. We look forward to a continued successful collaboration that contributes to Flemingsberg’s ongoing growth and success.”
– Anna Nyberg, Head of Business Development at Fabege
Flemingsberg is not just a place you pass – it’s a place on the move.
Welcome to join us, too!
Alfa Laval is a global leader in heat transfer, separation, and fluid handling. The company operates in the areas of energy, marine, pharma, food & water, offering its expertise, products, and services to a wide range of industries in around 100 countries. Alfa Laval is committed to optimizing processes, driving responsible growth, and enabling progress to support its customers in achieving their business and sustainability goals.
The company’s innovative technologies are dedicated to purifying, refining, and reusing materials, promoting a more responsible use of natural resources. They contribute to improved energy efficiency and heat recovery, better water treatment, and reduced emissions. In doing so, Alfa Laval not only accelerates success for its customers but also for people and the planet – making the world better, every day.
Alfa Laval has 22,300 employees. In 2024, its annual revenue was SEK 66.9 billion (approximately EUR 5.8 billion). The company is listed on Nasdaq Stockholm.
Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”
Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.
Evren Alici set to make cancer a liveable illness
A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.
Karin Mellström: “Co-operation is the key to success”
After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”
Matti Sällberg: “Vital to contribute facts to the debate”
During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.
